MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Movement disorders are the common signs as the first neurological deficit in cases with spinocerebellar ataxia type 2 (SCA2)

    N. Miyaue, R. Ando, T. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, H. Takashima, M. Nomoto (Ehime, Toohn City, Japan)

    Objective: We studied neurological signs in cases with SCA2 for early diagnosis. Background: SCA2 is a classification of hereditary ataxia, however, patients with SCA2 have…
  • 2016 International Congress

    Sporadic cerebellar ataxia associated with hypogonadotropic hypogonadism and PNPLA6 gene mutation. Case report in a Brazilian patient

    H.A.G. Teive, C.L. Boguszewski, S. Raskin, C. Buck, S.B. Seminara (Curitiba, Brazil)

    Objective: The aim of this study is to describe a case report of a Brazilian patient with sporadic cerebellar ataxia, associated with hypogonadotropic hypogonadism, and…
  • 2016 International Congress

    Depression and clinical progression in spinocerebellar ataxias

    S.H. Kuo, R.Y. Lo, K.P. Figueroa, S.M. Pulst, S. Perlman, G. Wilmot, C. Gomez, J. Schmahmann, H. Paulson, V.G. Shakkottai, S. Ying, T. Zesiewicz, K. Bushara, M. Geschwind, G. Xia, T. Ashizawa, S.H. Subramony (New York, NY, USA)

    Objective: To study the prevalence and influence of depressive symptoms in spinocerebellar ataxias (SCAs). Background: Depression is a common comorbidity in SCAs but its association…
  • 2016 International Congress

    Peripheral insulin sensitivity and body composition alterations in early stage Machado Joseph disease

    J.A. Saute, S.N. Gabriele, C.B. Haas, V.R. Torrez, A.W. Brochier, G.V. Furtado, T.C. Gheno, A.D. Russo, T.L. Monte, A. Schumacher-Schuh, R. D´Avila, K.C. Donius, R.M. Castilhos, D.O. Souza, M.L. Saraiva-Pereira, V.L. Torman, S.A. Camey, C.R.M. Rieder, L.V.C. Portela, L.B. Jardim (Porto Alegre, Brazil)

    Objective: To describe body composition and peripheral sensitivity to insulin (PSI) in early stage and presymptomatic spinocerebellar ataxia type 3/Machado Joseph disease (SCA3/MJD) individuals and…
  • 2016 International Congress

    Magnetic resonance imaging in spinocerebellar ataxias: A systematic review

    J.A. Saute, E. Reckziegel, M.C. França Jr, T.J.R. Ribeiro, L.M. Vedolin, L.B. Jardim, A.A. Klaes (Porto Alegre, Brazil)

    Objective: To perform a systematic review about quantitative central nervous system (CNS) magnetic resonance imaging (MRI) techniques findings in patients with Polyglutamine expansion (PolyQ) spinocerebellar…
  • 2016 International Congress

    Fiberoptic endoscopic evaluation of swallowing findings in patients with Machado-Joseph disease

    J.L. Pedroso, G.L.A. Diaféria, S.W. Park, L. Haddad, F.L.M. Haddad, O.P. Barsottini (São Paulo, Brazil)

    Objective: To describe the main findings of Fiberoptic endoscopic evaluation of swallowing (FEES) in patients with MJD. Background: Machado-Joseph disease (MJD) is a degenerative process…
  • 2016 International Congress

    Acute cerebellar degeneration as the first manifestation of Sjögren syndrome: A case report

    R. Maciel, S. Camargos, F. Cardoso (Belo Horizonte, Brazil)

    Objective: To report a case of acute ataxia with cerebellar atrophy as the presenting feature of Sjögren's syndrome (SS). Background: Cerebellar ataxia is rare in…
  • 2016 International Congress

    Cerebellar ataxia and pregnancy

    N. Hidarilak, T. Yacoubian (Birmingham, AL, USA)

    Objective: IVIG is a good treatment for autoimmune cerebellar ataxia (high anti-GAD antibody). Background: IVIG should be considered as a therapy for cerebellar ataxia related…
  • 2016 International Congress

    Psychogenic movement disorder in cerebellar atrophy

    P. Sommer, D. Földy, O. Khalifa, E. Fertl (Vienna, Austria)

    Objective: Description of a patient with psychogenic movement disorder showing cerebellar atrophy in neuroimaging. Background: Psychogenic movement disorders are typically characterized by abnormal involuntary movements…
  • 2016 International Congress

    Screening for SLC25A46 mutations in familial and sporadic ataxic patients

    S. Efthymiou, C. Bettencourt, H. Houlden (London, United Kingdom)

    Objective: To identify possible mutations of the SLC25A46 gene in patients with various forms of ataxia. Background: Members of the solute carrier family 25 (SLC25)…
  • « Previous Page
  • 1
  • …
  • 1626
  • 1627
  • 1628
  • 1629
  • 1630
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley